GlassScriptPhysician profile
Laura L Akers
NPI 1972565638
$3,736.56
in general payments reported to CMS, 2019-2025
29 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $899 · 2022: $997 · 2023: $877 · 2024: $712 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,841.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $841.33 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $495.01 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $309.15 | 2021-2023 | Watchman Access System |
| Amgen INC. | $286.00 | 2021-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $262.06 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $245.93 | 2021-2024 | Verquvo, Steglujan, Januvia |
| Pfizer INC. | $232.87 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $176.03 | 2021-2024 | Farxiga |
| Amarin Pharma, INC. | $134.35 | 2021 | |
| Sanofi-Aventis U.S. LLC | $133.79 | 2021-2023 | |
| Abiomed | $76.39 | 2022-2025 | |
| Getinge USA Sales, LLC | $62.55 | 2022 | |
| Alnylam Pharmaceuticals INC. | $48.27 | 2024-2025 | Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $45.19 | 2022-2023 | |
| Abbott Laboratories | $40.60 | 2021-2023 | Mitraclip |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $38.97 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Cvrx, INC. | $35.32 | 2024 | Barostim Neo System |
| Medtronic, INC. | $31.51 | 2022-2024 | Aurora Ev-Icd Mri Surescan |
| Cleerly, INC. | $29.08 | 2025 | Cleerly Labs, Cleerly Ischemia |
| E.R. Squibb & Sons, L.L.C. | $28.61 | 2021-2022 | |
| Daiichi Sankyo INC. | $28.09 | 2024 | Injectafer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.28 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $26.80 | 2022-2023 | Opsumit, Uptravi |
| Impulse Dynamics (USA) INC. | $22.52 | 2024 | Optimizer |
| Scpharmaceuticals INC. | $22.35 | 2025 | |
| Esperion Therapeutics, INC. | $16.42 | 2024 | Nexletol |
| Convatec INC. | $13.69 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $13.54 | 2023 | Inpefa |
| Kowa Pharmaceuticals America, INC. | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Akers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.